# Artificial Intelligence Assisted Insulin Titration System

> **NCT04053959** · PHASE4 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 46 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** AI assisted insulin system
- **DRUG:** Physician based insulin regime

## Key facts

- **NCT ID:** NCT04053959
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-27
- **Primary completion:** 2020-01-22
- **Final completion:** 2020-04-15
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04053959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04053959, "Artificial Intelligence Assisted Insulin Titration System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04053959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*